(MENAFN- The Costa Rica News) By TCRN STAFF September 28, 2021 11 0 Share Facebook Twitter WhatsApp Linkedin Email
Must Read Spiritual TCRN STAFF - September 28, 2021How To Close Cycles In Life Environment TCRN STAFF - September 28, 2021Costa Rican Nature and Fauna in Times of Pandemic Health TCRN STAFF - September 28, 2021The Marijuana Market and its Derivatives in Constant Advances TCRN STAFF Creating a Conscious alternative news network that we feel the world needs. Pura Vida!
The world evolves more and more, as well as the market for marijuana or cannabis , in addition to its derivatives included in hemp and even in CBD, better known as cannabidiol. Did you know that in Costa Rica, cannabidiol has gained momentum in the market , both in formal and informal trade. It is said that its popularity today is due to authorization in various edibles: beverages and oils.
It is worth noting that 80% of the products that contain CBD and that are allowed in the Central American country, were registered in this year 2021, after up to two years of procedures. Until these most recent days, it is known that there are five authorized articles taken into account as raw material, 10 for the cosmetics area, 32 (highest number) for food and only one as chemical (a citrus-based degreaser).
TIP: Get our latest content by joining our newsletter . Don't miss out on news that matter in Costa Rica. Click here .
Another important piece of information is that 10 of the aforementioned products were manufactured in national territory and the rest are imported specifically from the United States.
More information on cannabidiol
According to the Food and Drug Administration (FDA) cannabidiol or CBD, is a chemical compound in marijuana; it does not cause the psychotropic effect caused by another component of the plant called tetrahydrocannabinol better known as (THC). The World Health Organization (WHO) emphasizes that cannabidiol does not produce abuse or dependence in humans and that it is generally well tolerated with a good safety profile. Costa Rica will be territory for the cannabis operations of the manufacturer Valens
The Valens factory, a leader in cannabis products, will expand cannabis operations to Costa Rica, the Dominican Republic, and Panama. Valens is a division of Grupo Farmanova Intermed (GFI) Costa Rica, a pharmaceutical holding company that has operations throughout Central America and the Caribbean. Context before the world
Countries mainly in Latin America, exactly eight, have approved marijuana for medicinal purposes and two: Uruguay and Mexico, have legalized its use for recreational purposes. To be more specific, Uruguay was the first country in the world to legalize recreational marijuana. Mexico is the second country in Latin America to approve recreational use and it can be produced only for personal consumption. Although medical marijuana is not legalized in Brazil, the National Health Surveillance Agency (ANVISA), in 2017 included cannabis in the official list of drugs.
As we well know, in Costa Rica, cannabis is a substance prohibited by law, its production, distribution, and sale are criminally sanctioned. According to the National Survey on Drug Use of the country's Institute of Drugs and Drug Dependence, published in 2012, drug use is not considered a crime, but rather a public health problem .
Today, citizens of the Central American country continue to wait for the future of Bill 21,388 for the Production of Cannabis and Hemp for Medicinal Purposes. Almost a year has passed, which the Law was made known through Deputy Zoila Volio and the Costa Rican Government has remained without giving an answer. Let's talk about cannabis in the United States: 15 states in this nation, plus the District of Columbia now allow the recreational use of marijuana.
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.